Oncology Reports

Ras inhibitors
pp. 7-14(8)
Author: Hiwasa, T

Serum thymidine kinase as a tumor marker of colorectal carcinogenesis induced with 1,2-dimethylhydrazine in rats
pp. 15-16(2)
Authors: Kuwa, K; Kudo, H; Sakamoto, S

Tamoxifen in patients with advanced pancreatic adenocarcinoma
pp. 17-19(3)
Author: Mikulski, S

Radiation-induced heart disease
pp. 21-26(6)
Authors: Tritto, M; Calabrese, P

Transformed cells trigger induction of their own apoptosis in coculture with normal cells
pp. 27-31(5)
Authors: Hackenjos, K; Langer, C; Zabel, S; Bauer, G

Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2
pp. 33-40(8)
Authors: Monden, Y; Nakamura, T; Kojiri, K; ShindoOkada, N; Nishimura, S

Evaluation of MTX/5-FU sequential chemotherapy utilized MTT assay for gastrointestinal cancer
pp. 41-43(3)
Authors: Tani, M; Tanimura, H; Yamaue, H; Hotta, T; Iwahashi, M; Terasawa, H; Nakamori, M; Shono, Y; Nishimoto, N

Autologous mixed lymphocyte reaction and postoperative prognosis in patients with gastric carcinoma
pp. 45-48(4)
Authors: Iwahashi, M; Tanimura, H; Yamaue, H; Tsunoda, T; Tani, M; Noguchi, K; Mizobata, S; Tamai, M; Hotta, T; Arii, K; Terasawa, H

Stimulation of the expression of rhoB contributes to the ability of azatyrosine to convert c-erbB-2-transformed cells to a normal morphology
pp. 49-55(7)
Authors: Monden, Y; Nakamura, T; Kojiri, K; ShindoOkada, N; Nishimura, S

Expression of the retinoblastoma gene product in clinical thyroid tissues
pp. 57-62(6)
Authors: Ito, Y; Kobayashi, T; Takeda, T; Wakasugi, E; Tamaki, Y; Umeshita, K; Monden, T; Monden, M

Neural cell adhesion molecule expression in thyroid cancer
pp. 63-67(5)
Authors: Miyajima, Y; Ota, S; Yasukawa, H; Zenmyou, M; Morimatsu, M; Kashiwagi, S; Hirano, M

Serum soluble interleukin-2 receptor and immunohistochemical staining of IL-2R/Tac antigen in gastric cancer
pp. 69-73(5)
Authors: Murakami, S; Satomi, A; Ishida, K; Sakata, H; Tsuji, Y; Hibino, S

Expression of IGF-I, TGF-alpha and p53 protein in imprint smears of bronchial biopsy specimens of lung cancer
pp. 75-80(6)
Authors: Orphanidou, D; Athanasiadou, P; Toumbis, M; Petrakakou, E; Dimakou, K; Kyrkou, K; Rasidakis, A; Jordanoglou, J

Lectin bindings in non-neoplastic esophageal epithelium and esophageal carcinomas
pp. 81-85(5)
Authors: Shirai, K; Senzaki, H; Uemura, Y; Tsubura, A

Difference in histological activity of non-tumorous liver tissue between hepatitis B virus- and hepatitis C virus-associated hepatocellular carcinoma without cirrhosis
pp. 87-89(3)
Authors: Muro, T; Nakata, K; Kamito, H; Kato, Y; Nakao, K; Toriyama, K; Tsuruta, S; Shibata, Y; Arima, T; Nagataki, S

The retrospective assessment of surgical resection in the management of small cell carcinoma of the lung
pp. 91-94(4)
Authors: Mizushima, Y; Noto, H; Sugiyama, S; Kusajima, Y; Yamashita, R; Kobayashi, M

Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)
pp. 95-101(7)
Authors: Seregni, E; Foa, P; Bogni, A; Botti, C; Cataldo, I; Sala, M; Mezzetti, M; Gasparini, M; Santambrogio, L; Legnani, D; Bombardieri, E

The riminophenazine agents clofazimine and B669 inhibit the proliferation of intrinsically multidrug resistant carcinoma cell lines.
pp. 103-106(4)
Authors: VanRensburg, C; Theron, A; Chasen, P

Treatment results and long-term follow-up in stage I seminoma patients.
pp. 107-110(4)
Authors: Hofmockel, G; Theiss, M; Gruss, A

Granulosa cell tumor arising in the ovary irradiated 22 years earlier for endometrial stromal sarcoma.
pp. 111-113(3)
Authors: Kataoka, A; Nishida, T; Sugiyama, T; Yamanaka, H; Yakushiji, M

Emetic control in breast cancer patients receiving iv CMF
pp. 115-121(7)
Authors: Martin, M; Aranda, E; DiazRubio, E; Casado, A; Rubio, M; Valverde, J; LopezMartin, J; RodriguezLescure, A; Barneto, I; Gonzalez, R

A case of advanced endometrial cancer with lung metastasis effectively treated with carboplatin and pirarubicin intra-arterial administration
pp. 123-124(2)
Authors: Hasuo, Y; Nishida, T; Eguchi, H; Kuromastu, H; Tanaka, H; Sugiyama, T; Yakushiji, M

Inhibitory effect of genistein on a tumor promoter-induced c-fos and c-jun expression in mouse skin
pp. 125-128(4)
Authors: Wei, H; Barnes, S; Wang, Y

Treatment of hepatocellular carcinoma associated with extrahepatic primary cancer
pp. 129-132(4)
Authors: Une, Y; Ishizu, H; Uchino, J

Hyaluronic acid modulates glioma cell proliferation through its interaction with CD44H in vitro
pp. 133-135(3)
Authors: Koochekpour, S; Pilkington, G

Isolation of a cDNA for the human homolog of MAT-1 oncogene and its expression in human breast cancer cells
pp. 137-140(4)
Authors: Bandyopadhyay, G; Bera, T; Yang, J; Guzman, R; Nandi, S

Basic mutant Max reverses a c-Myc block to differentiation
pp. 141-146(6)
Authors: Cultraro, C; Cogliati, T; Hearing, L; Segal, S

Collagen markers during anticancer therapy for lung cancer
pp. 147-150(4)
Authors: Gabazza, E; Taguchi, O; Yoshida, M; Yamakami, T; Kobayashi, H; Shima, T

Antitumor effect of the angiogenesis inhibitor TNP-470 and its combination effect with 5-FU and PSK in colon 26 tumors
pp. 151-153(3)
Authors: Kitamura, M; Arai, K; Iwasaki, Y; Toi, M

ABCVEP (I) treatment for advanced intermediate grade and high grade non-Hodgkin's lymphoma
pp. 155-159(5)
Authors: Kuraishi, Y; Usui, N; Kobayashi, T; Nakamura, T; Yamazaki, H; Kaito, H; Unosawa, T; Kato, A; Mihara, H; Yano, S; Isogai, Y; Takagi, K

GTP-binding protein and its associated event in membranes from endometrial carcinoma
pp. 161-163(3)
Authors: Takagi, H; Imai, A; Horibe, S; Fuseya, T; Tamaya, T

Glycolytic profile in normal brain tissue and gliomas determined by a micro-method analysis
pp. 165-170(6)
Authors: Oudard, S; Miccoli, L; Guthauser, B; Vassault, A; Magdelenat, H; Dutrillaux, B; Poupon, M

Novel mouse repetitive element structures in an embryonal carcinoma mutant cell line
pp. 171-174(4)
Authors: Gama, R; Du, Y; Bauman, J; Chan, T; McCormick, P

Melanoma-specific cytotoxicity of a human MGSA/GRO alpha C-terminal peptide conjugated to daunorubicin
pp. 175-179(5)
Authors: Roby, P; Page, M

A Mr 7 kDa protein is present in both plasma and nuclear membranes in multidrug-resistant ovarian cancer cells
pp. 181-182(2)
Authors: Yang, X; Page, M

nm23-H1 protein immunohistochemical expression in human breast cancer
pp. 183-189(7)
Authors: Russo, A; Bazan, V; Morello, V; Valli, C; Giarnieri, E; Dardanoni, G; Cucciarre, S; Carreca, I; Bazan, P; Tomasino, R; Vecchione, A

Effect of hypoxia on the frequency of bleomycin-induced micronuclei.
pp. 191-195(5)
Authors: Hahn, K; Barnhill, M

Fluorescence polarization changes in the lymphocytic cytoplasm in the various stages of breast cancer
pp. 197-199(3)
Authors: Ron, I; Deutsch, M; Merimsky, O; Tirosh, R; Rachmani, H; Kaufman, M; Weinreb, A; Chaitchik, S

Stimulatory effects of amphetamine on the development of Walker-256 carcinoma lung metastases in rats
pp. 201-204(4)
Authors: FreireGarabal, M; NunezIglesias, M; Losada, C; PereiroRaposo, M; CastroBolano, C; Heras, J; Riveiro, P; Mayan, J; ReyMendez, M

Topical prostaglandin E2 and chemo- and radio-induced oral mucositis
pp. 205-208(4)
Authors: Maltoni, M; Sansoni, E; Derni, S; Milandri, C; Martini, F; Nanni, O; Fabbri, L; Amadori, D

DES-ja vu
pp. 209-212(4)
Authors: Schapira, D; Garland, L

Phorbol ester stimulated Cip1 expression in p53-negative leukemic cells
pp. 213-217(5)
Authors: DeVente, J; Bryant, W; Posekany, K; Garris, T; Chen, J; Carey, J; Cook, P; Ways, K

Antimetastatic effects associated with anticoagulant properties of heparin and chemically modified heparin species in a mouse mammary tumor model
pp. 219-222(4)
Authors: Alonso, D; Bertolesi, G; Farias, E; Eijan, A; Joffe, E; DeCidre, L

Effect of 5-fluorouracil treatment on IL-2R gene expression in gastric carcinoma patients
pp. 223-225(3)
Authors: Suresh, K; Jayavardhanan, K; Vasudevan, D